Report Detail
Global Perphenazine Market Insights, Forecast to 2025
- RnM2937741 |
- 13 February, 2019 |
- Global |
- 111 Pages |
- QYResearch |
- Pharma & Healthcare
Perphenazine is a typical antipsychotic drug. Chemically, it is classified as a piperazinyl phenothiazine. Originally marketed in the US as Trilafon, it has been in clinical use for decades. Perphenazine is roughly five times as potent as chlorpromazine, thus perphenazine is considered a medium-potency antipsychotic.
The global average price of Perphenazine is in the decreasing trend, from 6.95 USD/Unit in 2012 to 7.08 USD/Unit in 2016. With the situation of global economy, prices will be in increasing trend in the following five years.
The classification of Perphenazine includes Oral Forms and Injectable Solution, and the proportion of Oral Forms in 2016 is about 98%.
Perphenazine is widely used to treat psychosis and antiemetic. The most proportion of Perphenazine is used to treat psychosis, and the proportion in 2016 is 95%.
North America is the largest consumption place, with a consumption market share nearly 39% in 2015. Following North America, Asia Pacific is the second largest consumption place with the consumption market share of 25%.
Market competition is not intense. Teva, Sandoz, Endo, Mylan, ZHPHARMA, Shandong Boshan Pharma, etc. are the leaders of the industry, with high-end customers; have been formed in the monopoly position in the industry.
The global Perphenazine market is valued at 95 million US$ in 2018 and will reach 100 million US$ by the end of 2025, growing at a CAGR of 0.6% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Perphenazine market based on company, product type, end user and key regions.
This report studies the global market size of Perphenazine in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Perphenazine in these regions.
This research report categorizes the global Perphenazine market by top players/brands, region, type and end user. This report also studies the global Perphenazine market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Teva
Sandoz
Endo
Mylan
ZHPHARMA
Shandong Boshan Pharma
Market size by Product
Oral Forms
Injectable Solution
Market size by End User
Psychosis
Antiemetic
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Perphenazine market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Perphenazine market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Perphenazine companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Perphenazine submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Perphenazine are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Perphenazine market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Perphenazine Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Perphenazine Market Size Growth Rate by Product
- 1.4.2 Oral Forms
- 1.4.3 Injectable Solution
- 1.5 Market by End User
- 1.5.1 Global Perphenazine Market Size Growth Rate by End User
- 1.5.2 Psychosis
- 1.5.3 Antiemetic
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Perphenazine Market Size
- 2.1.1 Global Perphenazine Revenue 2014-2025
- 2.1.2 Global Perphenazine Sales 2014-2025
- 2.2 Perphenazine Growth Rate by Regions
- 2.2.1 Global Perphenazine Sales by Regions
- 2.2.2 Global Perphenazine Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Perphenazine Sales by Manufacturers
- 3.1.1 Perphenazine Sales by Manufacturers
- 3.1.2 Perphenazine Sales Market Share by Manufacturers
- 3.1.3 Global Perphenazine Market Concentration Ratio (CR5 and HHI)
- 3.2 Perphenazine Revenue by Manufacturers
- 3.2.1 Perphenazine Revenue by Manufacturers (2014-2019)
- 3.2.2 Perphenazine Revenue Share by Manufacturers (2014-2019)
- 3.3 Perphenazine Price by Manufacturers
- 3.4 Perphenazine Manufacturing Base Distribution, Product Types
- 3.4.1 Perphenazine Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Perphenazine Product Type
- 3.4.3 Date of International Manufacturers Enter into Perphenazine Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Perphenazine Sales by Product
- 4.2 Global Perphenazine Revenue by Product
- 4.3 Perphenazine Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Perphenazine Breakdown Data by End User
6 North America
- 6.1 North America Perphenazine by Countries
- 6.1.1 North America Perphenazine Sales by Countries
- 6.1.2 North America Perphenazine Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Perphenazine by Product
- 6.3 North America Perphenazine by End User
7 Europe
- 7.1 Europe Perphenazine by Countries
- 7.1.1 Europe Perphenazine Sales by Countries
- 7.1.2 Europe Perphenazine Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Perphenazine by Product
- 7.3 Europe Perphenazine by End User
8 Asia Pacific
- 8.1 Asia Pacific Perphenazine by Countries
- 8.1.1 Asia Pacific Perphenazine Sales by Countries
- 8.1.2 Asia Pacific Perphenazine Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Perphenazine by Product
- 8.3 Asia Pacific Perphenazine by End User
9 Central & South America
- 9.1 Central & South America Perphenazine by Countries
- 9.1.1 Central & South America Perphenazine Sales by Countries
- 9.1.2 Central & South America Perphenazine Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Perphenazine by Product
- 9.3 Central & South America Perphenazine by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Perphenazine by Countries
- 10.1.1 Middle East and Africa Perphenazine Sales by Countries
- 10.1.2 Middle East and Africa Perphenazine Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Perphenazine by Product
- 10.3 Middle East and Africa Perphenazine by End User
11 Company Profiles
- 11.1 Teva
- 11.1.1 Teva Company Details
- 11.1.2 Company Business Overview
- 11.1.3 Teva Perphenazine Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 Teva Perphenazine Products Offered
- 11.1.5 Teva Recent Development
- 11.2 Sandoz
- 11.2.1 Sandoz Company Details
- 11.2.2 Company Business Overview
- 11.2.3 Sandoz Perphenazine Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 Sandoz Perphenazine Products Offered
- 11.2.5 Sandoz Recent Development
- 11.3 Endo
- 11.3.1 Endo Company Details
- 11.3.2 Company Business Overview
- 11.3.3 Endo Perphenazine Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 Endo Perphenazine Products Offered
- 11.3.5 Endo Recent Development
- 11.4 Mylan
- 11.4.1 Mylan Company Details
- 11.4.2 Company Business Overview
- 11.4.3 Mylan Perphenazine Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 Mylan Perphenazine Products Offered
- 11.4.5 Mylan Recent Development
- 11.5 ZHPHARMA
- 11.5.1 ZHPHARMA Company Details
- 11.5.2 Company Business Overview
- 11.5.3 ZHPHARMA Perphenazine Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 ZHPHARMA Perphenazine Products Offered
- 11.5.5 ZHPHARMA Recent Development
- 11.6 Shandong Boshan Pharma
- 11.6.1 Shandong Boshan Pharma Company Details
- 11.6.2 Company Business Overview
- 11.6.3 Shandong Boshan Pharma Perphenazine Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 Shandong Boshan Pharma Perphenazine Products Offered
- 11.6.5 Shandong Boshan Pharma Recent Development
12 Future Forecast
- 12.1 Perphenazine Market Forecast by Regions
- 12.1.1 Global Perphenazine Sales Forecast by Regions 2019-2025
- 12.1.2 Global Perphenazine Revenue Forecast by Regions 2019-2025
- 12.2 Perphenazine Market Forecast by Product
- 12.2.1 Global Perphenazine Sales Forecast by Product 2019-2025
- 12.2.2 Global Perphenazine Revenue Forecast by Product 2019-2025
- 12.3 Perphenazine Market Forecast by End User
- 12.4 North America Perphenazine Forecast
- 12.5 Europe Perphenazine Forecast
- 12.6 Asia Pacific Perphenazine Forecast
- 12.7 Central & South America Perphenazine Forecast
- 12.8 Middle East and Africa Perphenazine Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Perphenazine Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Perphenazine . Industry analysis & Market Report on Perphenazine is a syndicated market report, published as Global Perphenazine Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Perphenazine market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
